ELAN vs. NTRA: Elanco Animal Health vs. Natera Stock Comparison

Company Profile

Elanco Animal Health (ELAN) and Natera (NTRA) both fall under the Pharmaceuticals, Biotechnology & Life Sciences industry group, but ELAN is classified in Pharmaceuticals while NTRA is classified in Biotechnology.

Price Performance

Cumulative Growth

Trailing Returns

Calendar-Year Returns

Performance Metrics

Risk Profile

Drawdown History

Return Distribution

Risk Metrics

Risk-Adjusted Performance

Risk-Return Positioning

Risk-Adjusted Metrics

Profitability

Elanco Animal Health (ELAN) has no ROE value reported for this period; Natera (NTRA) reports a negative figure of -10.55%, which needs context because negative ROE can reflect losses or negative shareholders’ equity.

Both Elanco Animal Health (ELAN) at -2.86% and Natera (NTRA) at -5.66% report negative net margin values, usually indicating net losses over the period.

Natera (NTRA) reports a negative operating margin of -7.64%, usually indicating that operating costs exceeded revenue at the operating-income line. Meanwhile Elanco Animal Health (ELAN) reports 6.64%, ranking against industry peers normally.

Profitability Metrics

Growth

Both Elanco Animal Health (ELAN) at 6.22% and Natera (NTRA) at 35.90% land near their industries' usual revenue growth ranges, so top-line momentum looks broadly in line with peers on both sides.

Only one side can be read here: Elanco Animal Health (ELAN) reports EPS growth of -169.12%, ranked against its industry; Natera (NTRA) has no EPS growth figure this period.

Growth Metrics

Financial Strength

Short-term liquidity can only be read on one side of this pairing: Natera (NTRA) shows current ratio of 2.81 against its industry benchmark, while Elanco Animal Health (ELAN) has no reading this period.

Both Elanco Animal Health (ELAN) at 0.64 and Natera (NTRA) at 0.13 fund their balance sheets with roughly industry-typical debt-to-equity mixes.

Financial Strength Metrics

Dividends

Neither Elanco Animal Health (ELAN) nor Natera (NTRA) pays a dividend this period — they may reinvest, use buybacks, or simply not return cash through dividends.

Neither Elanco Animal Health (ELAN) nor Natera (NTRA) pays a dividend this period — they may reinvest, use buybacks, or simply not return cash through dividends.

Dividend Metrics

Valuation

Neither Elanco Animal Health (ELAN) nor Natera (NTRA) reports a P/E ratio value for this period, so a direct comparison isn’t possible.

Elanco Animal Health (ELAN) at 2.50 sits in the cheaper P/S ratio quartile while Natera (NTRA) at 15.49 prices around its industry’s middle — ELAN costs less per dollar of sales, though read it alongside growth and margins.

Elanco Animal Health (ELAN) at 1.95 sits near its industry’s typical P/B ratio, while Natera (NTRA) at 23.99 prices above its benchmark range — NTRA looks rich relative to book.

Valuation Metrics